Alison Tanchyk

Alison is lead counsel for a client defending antitrust actions in multidistrict litigation (MDL) in the Eastern District of Pennsylvania and federal and state courts in Connecticut and involving suits brought by the state attorneys general for 48 states, class plaintiffs, and multiple direct action plaintiffs.

Alison is also lead counsel for a client defending civil RICO and fraud claims brought by multiple Medicare Part D sponsors and arising out of the US Department of Justice’s (DOJ’s) patient assistance program investigation.

She represented General Cable Corporation in connection with an FCPA investigation of General Cable’s business operations in Angola, Portugal, China, Egypt, and Thailand, resulting in a non-prosecution agreement and no compliance monitor. Alison also represented Olympus Corporation of the Americas in connection with an FCPA investigation of Olympus’s sales and marketing practices in Latin America resulting in a deferred prosecution agreement. She thereafter successfully defeated a lawsuit brought by the Mexican Social Security Institute against Olympus Latin America arising out of the government investigation. Alison regularly handles internal anti-corruption and accounting fraud investigations for clients across industries.

Alison is Chambers ranked for FCPA and Florida Litigation/White Collar Crime & Government Investigations. Since 2014, Alison has repeatedly been named by Latinvex as one of Latin America’s top Female Lawyers and was most recently named in 2024.

Alison is also the co-leader of the Florida Chapter of the Women’s White Collar Defense Association.

Anticorruption

• Defended General Cable Corporation in DOJ and Securities and Exchange Commission (SEC) FCPA investigations of the company’s business operations in Angola, Portugal, China, Egypt, and Thailand that resulted in a non-prosecution agreement with no compliance monitor.
• Represented Olympus Corporation of the Americas in an FCPA investigation of its sales and marketing practices in Latin America. Resulted in a deferred prosecution agreement and $22.8 million fine.
• Represented key government witness in United States v. McDonnell Virginia corruption trial.
• Represented a Fortune 100 company in an FCPA internal investigation in Korea and China involving related inquiries by the DOJ and SEC.
• Defended a Fortune 100 company in an FCPA internal anticorruption and anti-competition investigation in Vietnam and Singapore and related inquiries by the World Bank.
• Represented multiple corporations in internal investigations involving allegations of violations of the FCPA and foreign anti-corruption laws in Asia, Southeast Asia, Africa, Eastern Europe,
• Central America, South America, Russia, and the Middle East.

Antitrust

• Lead counsel for a client defending antitrust actions in MDL in the Eastern District of Pennsylvania and federal and state courts in Connecticut and involving suits brought by the state attorneys general for 48 states, class plaintiffs, and multiple direct action plaintiffs.
• Declination of prosecution of corporation in a federal criminal antitrust action involving, inter alia, allegations of price fixing and bid-rigging.

Healthcare Fraud and Abuse

• Defense of pharmaceutical company in DOJ litigation alleging that the company conspired with charitable foundations to funnel co-pay assistance to Medicare patients in violation of the AKS and FCA.
• Cross-border healthcare fraud internal investigation involving allegations of fraudulent billing and bid-rigging.
• Representation of pharmaceutical manufacturers in connection with DOJ criminal and civil investigations involving allegations of, inter alia, off-label marketing.
• Representation of healthcare provider owners in connection with DOJ criminal and civil investigation of alleged conspiracy to commit healthcare fraud and money laundering.

Results may vary depending on your particular facts and legal circumstances.